Mabron 150mg modified-release tablets (Teva)
BNF presentation 040702040BHAEAD within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040702040BHAEAD
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
33
NHS spend (£)
£554.26
Recent activity
July 2021
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| July 2021 | 1 |
| December 2020 | 13 |
| November 2020 | 19 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
|
Atlantic Medical Group
ODS L82038
|
8 | 11N - CORNWALL & THE ISLES OF SCILLY ICB |
|
Abbey Medical Practice
ODS M81094
|
3 | 18C - HEREFORDSHIRE & WORCESTERSHIRE ICB |
| Unknown pharmacy | 3 | No data available |
|
Upper Eden Medical Practice
ODS A82013
|
2 | 01H - NORTH EAST AND NORTH CUMBRIA ICB |
|
Tasburgh Lodge Surgery
ODS C83634
|
2 | 71E - LINCOLNSHIRE ICB |
|
Culverhay Surgery
ODS L84027
|
2 | 11M - GLOUCESTERSHIRE ICB |
|
Quantock Medical Centre
ODS L85013
|
2 | 11X - SOMERSET ICB |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 1 | No data available |